SCHEMBL29348266

SCHEMBL29348266

CCN1C(=O)OCC12CCC2

nearest known ligand 0.40

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23469844 0.92 PIK3CD (0.33) PIK3CD
SCHEMBL7406886 0.84 CHRM2 (0.39) PIK3CD
SCHEMBL14401481 0.77 PIK3CD (0.44) PIK3CD
SCHEMBL14376295 0.77 PIK3CD (0.41) PIK3CD
SCHEMBL29348259 0.74 PIK3CD (0.32) PIK3CD
SCHEMBL29349121 0.74 IDH1 (0.31)
SCHEMBL13270729 0.74
SCHEMBL29348256 0.72
SCHEMBL23432883 0.72
SCHEMBL13379880 0.69 IDH1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024151547-A1 TARGETED DEGRADATION OF VAV1 MONTE ROSA THERAPEUTICS, INC. (US) 2024-07-18 WO disclosed